As gene therapies move toward commercialization, a robust, scalable, and affordable manufacturing process is critical to ensure these novel therapies reach the patient and that a pipeline of clinical assets can be rapidly developed. Join us to hear how Pall Corporation, Cytiva and Precision NanoSystems (PNI) have successful technologies that help the industry with potential solutions.

Agenda:

Dana Pentia, PhD, Pall Corporation

Accelerating the Industrialization of Genomic Medicine

Ian Villamagna, PhD, Precision NanoSystems

Utilizing the Genomic Medicine Toolkit for Development of Novel Cell and Gene Therapies

Leticia R. Regis, PhD, Pall Corporation

A Novel Two Step Purification Process for Plasmid DNA

Pierre Tremblay, PhD, Cytiva

Scalable rAAV Process

Networking reception 4:00 to 5:00 PM